Tennessee Senate Bill SB0422

Tennessee 2025-2026 Regular Session

• Introduced: 1/28/25

Caption

AN ACT to amend Tennessee Code Annotated, Title 8; Title 47; Title 56; Title 63 and Title 71, relative to medical devices.

Impact

The implications of SB0422 are significant as it alters the legal landscape surrounding medical devices. By amending the existing timeline, the bill may affect how manufacturers, healthcare providers, and legal entities engage with medical device legislation. The shorter period for citation could lead to more rapid resolutions in disputes over medical devices, thus impacting patient safety and regulatory compliance discussions. Additionally, this change could influence how companies manage their product liability and compliance strategies in Tennessee.

Summary

Senate Bill 0422 is a legislative proposal aimed at amending various sections of the Tennessee Code Annotated, specifically focusing on the regulation and oversight of medical devices. This bill seeks to change the timeframe related to the citation of medical devices in legal contexts, reducing the established period from three years to two years. The primary intent appears to be streamlining the regulatory framework governing medical devices within the state, potentially enhancing efficiency in legal proceedings associated with such products.

Contention

Despite the bill’s straightforward objective, discussions surrounding SB0422 may reflect broader tensions in legislative approaches to health regulation. Stakeholders may express differing opinions on the adequacy of a two-year period for compliance and citation. Proponents are likely to argue that this adjustment promotes quicker resolution of disputes, thereby benefiting both consumers and manufacturers. Conversely, opponents may contend that this shortened timeframe could undermine the oversight needed to ensure product safety and effectiveness. Debate may also ensue over the potential implications for public health if key regulatory protections are diminished.